Company news
Medicure Inc. (TSXV:MPH) news
Every Medicure Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
August 14, 2026
Medicure Announces CFO Change
July 3, 2026
Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
May 21, 2026
Medicure Announces AGM Results and Appointment of New Director
May 21, 2026
Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
April 23, 2026
Medicure Announces Resignation of President and Chief Operating Officer
April 17, 2026
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2025
November 20, 2025
Medicure Reports Financial Results for Quarter Ended September 30, 2025
November 19, 2025
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
November 13, 2025
MEDICURE : ANNOUNCES UPDATE ON ENROLLMENT IN ITS MEND-PNPO PHASE 3 CLINICAL TRIAL AND PRESENTATION OF THE TRIAL DESIGN AND BASELINE DATA ...
September 23, 2025
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2025
August 21, 2025
Medicure Reports Financial Results for Quarter Ended June 30, 2025
August 20, 2025
MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 21, 2025 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2025
August 19, 2025
Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025
August 18, 2025
Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy
June 17, 2025
Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results
May 21, 2025
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
April 25, 2025
Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024
April 22, 2025
Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia...
April 11, 2025
Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
March 11, 2025
Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Phar...
February 18, 2025
Medicure Reports Financial Results For Quarter Ended September 30, 2024
November 25, 2024
Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignat...
November 18, 2024
Medicure Announces Positive Settlement of Product Development and Supply Contracts
October 24, 2024
Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
August 14, 2024
Medicure Reports Financial Results for Quarter Ended June 30, 2024
August 14, 2024
Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
June 24, 2024
Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
May 28, 2024
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
April 23, 2024
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
April 8, 2024
Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
April 4, 2024
Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans w...
December 5, 2023
Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
November 23, 2023
Medicure Reports Financial Results for Quarter Ended September 30, 2023
November 21, 2023
Medicure Reiterates its Commitment to Providing Exceptional Access to its Branded Pitavastatin (Zypitamag) to People Living With HIV
August 29, 2023
Medicure Reports Financial Results For Quarter Ended June 30, 2023
July 28, 2023
Medicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023
July 24, 2023
Medicure Reports Financial Results for Quarter Ended March 31, 2023
May 26, 2023
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2022
April 6, 2023
Medicure To Present Financial Results on April 10, 2023 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2022
April 5, 2023
MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS
February 1, 2023
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022
November 24, 2022
MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022
November 17, 2022
EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.
September 26, 2022
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2022
August 24, 2022
MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2022
August 17, 2022
MEDICURE ANNOUNCES RESULTS OF 2022 AGM
June 20, 2022
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2022 AND APPOINTMENT OF HAARIS UDDIN AS CHIEF FINANCIAL OFFICER
May 30, 2022
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2021
April 27, 2022
MEDICURE TO REPORT FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021 ON APRIL 28TH AT 7:30 AM CST
April 26, 2022